chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reports  sleeping more that normal (18-20 hrs first night), and sleeping more that normal past week. reports fatigue, poor appetite some nausea. Dizziness that comes and goes.. Denies fever. States S/S have improved but still there after 1 week.
dizziness; achiness behind my eyes for 16 days; This is a spontaneous report from a contactable healthcare professional (patient). A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration at the left arm on 14Jan2021 at 12:30 PM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was a hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included penicillin allergy.  There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (lot number: EK5730) on 26Dec2020 at 03:30 PM (at the age of 45 years old) at the left arm for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. On 16Jan2021 at 09:00 AM, the patient experienced dizziness and achiness behind her eyes for 16 days. The patient did not receive treatment for the events. The events were reported as non-serious. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has been tested for COVID-19 which included Nasal Swab: Negative on 31Jan2021.  The outcome of the events was not recovered.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Medium
Approximately 11/1/00, 198 days post vax, the pt began experiencing mild headaches. She has not sought medical attention. The headaches persisted as of 12/6/00.
Mom came back after vaccination of Comvax, Prevnar and Hepatitis A were given.  Child had hives on face and legs.  No respiratory distress noted.  Child evaluated by doctor. No signs of anaphylaxis noted. Child found to be well.  Hives diminished after 5 minutes.  Mom informed to stay for 20 more minutes.  Mandatory # 2 Hepatitis A will not be given due to reaction.
Approximately 12 hours after vaccination, patient complained of chills, diaphoresis, and was shaking.  Symptoms continued at least 24 hours. Before patient took temp (oral) 103.4.  Medical attention sough 10/23 Theraflu and Tylenol prescribed.
Received vaccine on May 12, 2021, developed dry cough and sore throat that lasted about two weeks. Then got three blister like itchy spots on back, thought it was bug bites, very painful.  I then started getting chest pain that radiated from the blisters. Went to Dr.  and she said it was possibly shingles, but not typical. I still have chest pain, same area especially on exertion. I was otherwise healthy until the vaccine.
The patient returned to the pharmacy on Monday morning, two days after the injection.  She stated that Saturday evening (the night of the injection), her arm developed a large knot where the vaccination had been injected.  She rubbed the area to try and rub the knot out.  The next morning she woke up to her entire left bicep area red, swollen, and feverish.  She went to the doctor two days later (on Monday) and received a steroid dose pack and an antibiotic in case an infection had set up in the area.  Her arm was not swollen when she picked up her medications, but it was still red in a certain area.
left arm was tender; Cramping feeling and feels like spasms; muscles were sore on the left side; This is a spontaneous report from a contactable consumer.  This consumer (patient) reported that a 42-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN5318) at the age of 42-years, via an unspecified route of administration in left arm on 31Jan2021 at single dose for COVID-19 immunization, in workplace clinic. Medical history included shell-fish allergy. No other vaccine in four weeks, no COVID-19 prior vaccination. Patient was tested negative for COVID-19 virus test (Nasal Swab) on 25Jan2021. No other medications in two weeks. At 00:00 on 17Feb2021 (16Feb2021 12:00 PM), the patient experienced left arm was tender and muscles were sore on the left side. Cramping feeling and feels like spasms. Patient went to the hospital cause of pain. The adverse events resulted in emergency room/department or urgent care. No treatment. On an unspecified date, COVID-19 was tested post vaccination with unknown results. Outcome of the events was unknown.
Patient received vaccine on 4/13/18. On 4/16/18, she noticed redness about 3-4 inches in diameter at the injection site. On 4/17/18, she noticed the area was hot to the touch. On 4/18/18, she noted tiny white blisters had formed on the area. She states that it does not hurt so she has not taken anything to try to remedy the reaction.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 12-MAY-2016, the patient was vaccinated with improperly stored VARIVAX (which had a lot # of L042265 and an expiration date of 26-OCT-2017; however, dose, dosage number, route of administration and anatomical location were not reported). Information regarding concomitant therapies was not provided. The vaccines experienced a temperature excursion of 10 F for a time frame of 3 hours and 16 minutes. Reportedly, no previous temperature excursions had occurred and the aforementioned one was called out due to a data logger. Despite being vaccinated with such an improperly stored vaccine, no adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Exactly 1 week from vaccination, menstruation began approximately 2 weeks before schedule and roughly 10-12 days after date of start of previous cycle. Heavy with many clots, extreme fatigue, headache, and heavier than usual cramping. Completely unexpected and NOT accompanying any usual, predictable signs of PMS or anticipated cycle.  Women need to know this is happening.
mom called about 4PM 15MAY97;states pt had screamed since was given vax;could not calm;parent to take child to MD:no localized redness or edema to child legs;MD felt pt had a rxn to pertussis & to have DT from now on;
Patient complained of starting to feel shaky in her hands and lips. Denies any other symptoms. Benadryl 25mg given. Patient reported feeling better after 30 minutes. Mother came to pick up the patient. Advised to follow up with PCP or go to the ER if continued to have any problems. Vitals remained stable
Information has been received from a Registered Nurse (R.N.) concerning a 17 year old female patient who on 10-JAN-2007 was vaccinated with her first dose of Gardasil. On 03-MAR-2007 she was vaccinated IM in her left deltoid with her second dose of Gardasil, lot #654540/0800F. Concomitant therapy included oral contraceptives (unspecified). Shortly after the administration of her second dose,
pt recv vax & failed to seroconvert;pt recv 3rd dose but titers were still undetectable;
Arm began itching on day 5 after injection.  The itching progressed, became red around the injection site and the redness expanded down the arm (to the elbow) and around the arm front and back until it met at the bicep.  This has lasted for 7 days so far....  It is much better but still a bit red and itching a small bit.
p/vax pt exp vomiting & bad h/a;taken to pMD by mom;PMD stated it was a rxn to the vax & not to recv another;no rx given;instructed to go home & rest;
On the ninth evening after vaccination large red hives appeared near the vaccination site. The area got quite swollen and hot to touch.  There was no itching or pain, just swelling and hives.  The next day the swelling subsided, hives got smaller, but the area of sking was still red and warm. That same day, I also got chills and felt like I was coming down with a cold, but that went away by the next day.
Client (DOB 01/07/2021) received the COVID vaccine (Pfizer dose 2, lot # EW0186, expiration date 7/12/2021) at 1333. EMT observed the client sitting in the observation area fanning herself at 1340 and offered her a bottle of water and a seat closer to the door (for the breeze), which the client accepted. At 1342, the client reported "trouble breathing" and her heart "beating hard." The client appeared pale and diaphoretic, but didn't have any increased work of breathing. The client denied any dizziness or changes in vision. The client was alert and oriented x4. At 1345 ,the client's vital signs were as follows: blood pressure 152/92, heart rate 88, O2 98%, respiratory rate 16. The client stated that they have a medical history of diabetes and they take Metformin as their only medication. The client denied having any allergies and stated that they ate last 2 hours before their appointment. The client denied chest pain but stated that her chest felt "tight". The client declined Benadryl and EMS activation at this time. At 1350, the client's vital signs were as follows: blood pressure 128/86, heart rate 84, O2 96%, and respiratory rate 16. The client stated that her heart still felt "the same" but that her chest tightness had resolved. The client stated she was experiencing dizziness but denied any vision changes. The client was no longer diaphoretic and her skin color had returned to normal. The client denied any nausea, rashes, or chest pain. The client continued to be alert and oriented x4. She  was sitting in her chair, resting comfortably. At 1355, the client's heart rate was 72, her respiratory rate was 14, and her O2 was 99%. The client stated her dizziness had resolved at that time. Education was provided by RN and EMT regarding primary care follow up, v-safe, and emergency management. At 1405, the client's vital signs were as follows: blood pressure 128/84, heart rate 74, O2 96%. The client stated her heart still felt as if it was "beating fast" but had improved. She was able to stand without any dizziness. At 1410, the client ambulated to her car with a steady gait, escorted by her spouse, who drove her home.
Patient received Pfizer 1st dose afterwards develop L arm pain and L trunk numbness resolved on own started day after vaccine and resolved after three weeks.  After 2nd dose developed shortness of breath and bilateral pulmonary emboli, started four weeks after second dose and is still being resolved now with anticoagulation therapy.
Soreness at injection site as well as sharp nerve pain at shoulder when lifting arm. She expresses concern that the injection was administered too high up on the shoulder. She has limited range of motion due to pain when lifting farther than elbow height.
After 40 minutes burning in my eye, swelling in my eyelid, facial rash, small puffy welt under eye
Hypertension 226/136; Felt dizzy; Sick; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 07Jan2021 (at the age of 74-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Two days after dose 1 of BNT162B2 (09Jan2021) the patient experienced hypertension, felt dizzy, and sick. The patient had not experienced dizziness and hypertension before. She decided not to receive dose 2 of BNT162B2 and wanted to know if it was too late to receive dose 2. The patient underwent lab tests and procedures which included blood pressure measurement of 226/136. The outcomes of hypertension, felt dizzy, and sick were unknown.  No follow-up attempts are possible. Information about lot/batch cannot be obtained.
MY LYMPH NODES SWOLL UP FOR A WEEK IN  MY NECK AND NOW I THINK A LYMPH NODE IS SWOLLEN IN THE BACK OF MY HEAD
Cellulitis with fever & pain into left axillary.  Benadryl & doxycycline prescribed. Severe symptoms started 7 days s/p injection
She received Pfizer dose on 5/11/2021 lot number EW0171.  She received Moderna as a second dose.  No adverse reaction noted at the time of the report.
Extreme dizziness, weakness, numbness/tingling in arms and legs especially right leg and foot. Bed rest and lots of fluids. As of today May 31, symptoms are clearing but still some numbness in right leg and foot.
Syringe used to give vaccination seemed to be defective. After giving the vaccination, some of the liquid dripped out of the patient's arm. She did not receive the full dose.
Chest pain, centralized, worse at night. History of sports asthma, no attack in years.
1st dose was administered 2/29/2020, and second dose was given 8/30/2020. After the second dose she said she developed a rash/tiny blisters on her forehead/into hairline on half of her face. She said the rash appeared about five days after the second dose, cleared in about a week to week & 1/2 later and then came back about a week & 1/2 later. It then cleared again and hasn't returned.
Expired vaccine by the time of admin. No harm done. Patient will come in for a replacement dose.
Patient presented to hospital on 7/21 for evaluation of easy bruising and low platelets.  She received gardasil vaccination on 7/15/20 in MD office.  On Thursday, pinpoint spots on her skin from knees to feet were noticed.  On Friday, the spots got more prevalent and larger with a large bruise on her right inner thigh.  The pressure points also had an increased number of spots.  She felt shaky, tired, increased thirstiness, and dry blood in mucous.  Patient was admitted and has received 2 doses of IVIG (on 7/22 and 7/23).
NEEDLE WITH HUB DISLODGED FROM SYRINGE DURING ADMINISTRATION, CLIENT REICEVED .15ML OF VACCINE, WHILE THE OTHER .15ML DRIPPED OUT OF SYRINGE DOWN CLIENT'S ARM.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 53-year-old male patient who received SHINGRIX for prophylaxis.  The patient's past medical history included migraine and cold sores. Concurrent medical conditions included attention deficit/hyperactivity disorder. Concomitant products included acyclovir, atorvastatin calcium (Atorvastatin), bupropion hydrochloride (Bupropion), lansoprazole, losartan potassium (Losartan) and metformin hydrochloride (Metformin). On 8th May 2018, the patient received the 1st dose of SHINRIX. On 8th May 2018, immediately after receiving SHINGRIX, the patient experienced influenza-like symptoms, loss of energy and feeling unwell. On 13th May 2018, the patient experienced scalp pain. On an unknown date, the patient experienced migraine. On an unknown date, the outcome of the influenza-like symptoms, scalp pain, migraine, loss of energy and feeling unwell were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, scalp pain, migraine, loss of energy and feeling unwell to be related to SHINGRIX. Additional information was received as follows: The patient did not feel so great immediately after receiving the SHINGRIX and he felt flu like symptoms with no energy. The patient stopped the acyclovir which he was taking for migraines, he had no migraines and no cold sores. The patient had denied permission to contact their physician. This case has been linked to the case US2018GSK124064, reported by the same reporter.
slight pains in the chest; Chills; didn't cough up phlegm anymore; This is a spontaneous report from a contactable consumer (Patient). A 52-years-old female patient received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0151), dose 1 via an unspecified route of administration, administered in Arm Left on 02Apr2021 09:30 as DOSE 1, 0.3 ML SINGLE for covid-19 immunisation (at the age 52 years). Medical history included ongoing chronic obstructive pulmonary disease Diagnosed in 2020, maybe June 2020, ongoing blood pressure measurement Had it for years maybe 5 or 6 years, malaise from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced on Apr2021 slight pains in the chest, chills, didn't cough up phlegm anymore. It was reported that, outside she has the chills, but one thing she is concerned about is she has history COPD. Before she took the shot she had phlegm that she coughed up in the morning. When she took the first shot she didn't cough up phlegm anymore and same with second. She has not been coughing up phlegm since. She is wondered if she should be concerned. She wanted to know if she should be concerned because if it is not coming up where is it. She has had slight pains in the chest. Pain is not like pain, but is a nagging. It wont' go away. They have been there since the first shot, but it would come and go. After second shot, it is constant now. The pain is in the left side. She had physical problems, but nothing with breathing. She has high blood pressure. Questioned is that a concern. Maybe the fluid is not leaving the lungs and is still in there. And also reported age adverse event started 52 but she is not really sure. Then caller clarified that it her age is 52 because she turns 53 this year. She hadn't had a chest x-ray since having the vaccine. Reporter stated, time the vaccination was given her appointment for first dose was at 9:30 in the morning. The patient underwent lab tests and procedures which included she did have blood work done way after the first dose, maybe less than a month ago. They said everything was alright on an unknown date. The patient did not visited emergency room and physician office. The clinical outcome of the events was not recovered. Information on Lot/Batch number was available. Additional information has been requested.  Follow-up attempts completed. No further information expected.
no adverse effect reported; The patient was inadvertently administered VARIVAX and PROQUAD; This spontaneous report has been received from a license practical nurse regarding to a patient of unknown age and gender. Patient's concurrent condition, medical history, concomitant medication and drug allergies or reaction were not provided.   On 28-MAR-2019, the patient was inadvertently vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX), lot # R013563  and expiration date 13-MAY-2020, and a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) Lot # R024020 and expiration date 19-FEB-2020 (also reported as 19-FEB-2019) (overdose); both vaccines were  reconstituted with a properly stored diluent  and were administered for prophylaxis (dose, route of administration and anatomical location of vaccines were not reported). No adverse effect was reported.
Patient was given an expired dose of VAQTA; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.    On 10-NOV-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # S030588 with expiration date of 20-OCT-2020 (strength,  dose, route, frequency, and anatomical location were not provided) for prophylaxis (expired product administered). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S030588; expirationdate: 20-OCT-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Rash down arm and itching/Experienced rash, itching, at the injection site; Rash down arm and itching/Experienced rash, itching, at the injection site; Experienced rash, itching, and warmth at the injection site; This is a spontaneous report from a contactable nurse. This nurse reported for three patients. This is 1st of three reports. A 65-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, strength: 0.5 ml, Batch/lot number: CK0842, NDC number: 0005-1971-02, Expiry date: 28Feb2022), intramuscular in the left arm on 19Jun2020 13:20 at 0.5 mL, single dose for prevention of pneumonia. Medical history was none. There were no concomitant medications. Pneumococcal 13-val conj vac (dipht crm197 protein) was given to the patient who then experienced rash, itching, and warmth at the injection site on an unspecified date of Jun2020. The patient experienced rash down arm and itching on 24Jun2020. Additional vaccines administered on the same date of the pfizer suspect was none. Events requiring a visit to emergency room or physician office was no. Prior Vaccinations (within 4 weeks) was none. Family medical history relevant to events was none. No relevant tests. The outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020248408 same reporter/drug/event, different patient
Arm swelled. Swelling did not go down till 8/13/2020. 10 days later.
Pain; swelling; redness; itching at injection site came back one week after vaccination. Rash appeared around injection site.
Patient had no adverse reaction to vaccination but was given the wrong dose of vaccination. Patient was injected with Pfizer vaccination designated for children 5-11 years of age due to staff error.
Information has been received from a registered nurse concerning a 14 week old (three months and 14 days old) patient who on 02-NOV-2010 was vaccinated IM with a pediatric 0.5 ml dose of VAQTA (lot number not provided) in pace of hepatitis B virus vaccine. No adverse effect was reported. Additional information has been requested.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
pt recv vax in daytime & several hr later mom reported swollen red lt thigh & refusal to move lt leg, inconsolable crying;seen in ER dx local rxn to tetramune;nl behavior & use of leg;no lethargy, no fever;
strong abdominal pains; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A child female patient received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN (non-serious) with onset Nov2021, outcome "recovered" (Nov2021), described as "strong abdominal pains". Additional Information: Patient had received her first does the Pfizer COVID-19 vaccine three days prior. She reported this to VAERS as a possible adverse event.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2 inch in diameter redness that is warm to the touch and skin is swollen around the injection site.